CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Participants will be randomized to receive the Companeros en Salud diabetes self-management education and support (DSMES) intervention with ...
Seattle, Washington, United States and 1 other location
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Seattle, Washington, United States and 17 other locations
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
Tacoma, Washington, United States and 9 other locations
Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...
Seattle, Washington, United States and 64 other locations
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Seattle, Washington, United States and 24 other locations
of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...
Phase 4
Seattle, Washington, United States and 35 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Bellevue, Washington, United States of America and 42 other locations
double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...
Phase 2
Seattle, Washington, United States and 54 other locations
BLOOD FLOW AND BLOOD-BRAIN BARRIER PERMEABILITY IN TYPE-2 DIABETES (T2D) through testing of the intervention on patients in a clinical setti...
Phase 4
Seattle, Washington, United States
Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...
Seattle, Washington, United States and 37 other locations
Clinical trials
Research sites
Resources
Legal